key: cord-0790722-iyw6qar4 authors: Jara, Luis J.; López-Zamora, Berenice; Ordoñez-González, Irvin; Galaviz-Sánchez, María F.; Gutiérrez-Melgarejo, Caroline I.; Saavedra, Miguel A.; Vera-Lastra, Olga L.; Cruz-Domínguez, María Pilar; Medina, Gabriela title: The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases date: 2021-09-10 journal: Autoimmun Rev DOI: 10.1016/j.autrev.2021.102946 sha: d8e8a1ed66bbe36eec822080022cb9cbcbcbf3cb doc_id: 790722 cord_uid: iyw6qar4 • The immune-neuroendocrine system is essential to maintain homeostasis specially during stress situations. COVID-19 infection, produce stress, and activates the immune–neuroendocrine system. During the COVID-19 pandemic, multiple studies indicate that the most vulnerable populations are older adults and patients with comorbidities including autoimmune rheumatic diseases. These patients suffer from extremely important situation that favors the inflammatory hyper response due to an inadequate reaction of the immune-neuroendocrine system. This review aims to analyze the findings of the effect of COVID-19 on the hypothalamic–pituitary–adrenal, hypothalamic–pituitary–gonadal, hypothalamic–pituitary–thyroid, hypothalamic–pituitary–prolactin axes, and central nervous system, as well as the response to this viral infection in older adults and patients with rheumatic diseases and perspectives about this subject. In nearly 80% of COVID-19-infected patients, the disease will be mild and restricted to the upper airways. About 20% of infected patients will develop atypical pneumonia and around 2% of these will develop a very severe disease [5] . High mortality has been observed in people over 65 years of age and with comorbidities such as diabetes mellitus, arterial hypertension, obesity, autoimmune diseases, and others [6]. At this time, biomarkers of morbimortality have been identified: The first axis that is activated after a viral infection and stress situation is the hypothalamic-pituitary-adrenal (HPA) axis. The proinflammatory cytokines gland and consequently releasing the adrenocorticotropic hormone (ACTH), ending with the release of corticoids by the adrenal glands [23, 25] . These corticoids yield negative feedback on immune cells, which suppress the synthesis and release of the cytokines TNF-α, IL-1β, and IL-6 [23]. Another function of glucocorticoids is to change from Th1-to Th2-type immune responses, thus counterbalancing damage to the tissues [24] . The HPA axis has receptors at every level for cytokines and it was demonstrated that this axis can also synthesize the latter [25] . Cytokines cross the BBB, which is an integral part of the immune-neuroendocrine system [26] . There are several identified ways as to how cytokines cross the BBB as follows: stimulating afferents pathways that project to the nucleus tractus solitarius, activating norepinephrine in the PVN; crossing the BBB at damaged regions; exerting a direct effect on CRH in the medium eminence, and inducing/releasing secondary messengers and crossing the BBB by active transport [24] . The BBB is injured by the TNF-α and IL-6 participating in neuroinflammation. TNF-α allows depolarization of the BBB endothelial cells and IL-6 production with the consequent stimulation of immuneneuroendocrine system [26] . Anosmia and ageusia demonstrate the direct involvement of SARS-CoV-2 and cytokines on the central nervous system (CNS). In this respect, histological studies obtained on the olfactory epithelium have shown that TNF-α levels were significantly high in patients infected with COVID-19 compared to those of a control group [29] . Early studies found on tonsilitis a local production of proinflammatory cytokines and its relationship with catecholamine receptors [30] . Based on these findings, an immune-neuroendocrine interaction has been proposed. In fact, the SARS-CoV-2 virus is neurotropic [26] . COVID-19 infection alters the stress response system, and this alteration contributes to the worsening of elderly patients or those with an autoimmune disease. In fact, patients severely infected with COVID-19 exhibited significantly lower cortisol levels than severely infected non-COVID-19 patients [31]. Another study evaluated adrenocortical function in a group of patients with COVID-19 in which the study's findings suggest an inadequate response of the HPA axis [32] . In support of these findings, an autopsy study of COVID-19 patients revealed enlarged hematomas, diffuse bleeding, thrombus, necrosis, and the inflammatory infiltrate of adrenal glands. Taken this evidence together, COVID-19 has a devastating effect on the hypothalamicpituitary-adrenal axis, that is, the principal stress response system [33] . this response [34] . Experimental models revealed that male rodents had a worse outcome after a Hepatitis B infection due to the immunosuppressive activity of testosterone. Another example was that after an Influenza A virus infection, female mice had a greater inflammatory response than males [35] . These examples clearly demonstrate the relation between these two systems, and this has also been studied for the SARS-COV 2 infection. It was observed that men present more complications than women, this due to the levels of androgens, particularly in the expression of a gene, TMPRSS2, whose transcription is regulated by androgen receptors [36] . With regard to ACE2 receptors and SARS-CoV-2 interaction, estrogens and androgens increase their expression [37] . It was evidenced that the hypothalamic-pituitary-gonadal axis can be directly affected by COVID-19, destroying Sertoli cells and Leydig cells, causing a worsening of spermatogenesis and a decrease in testosterone levels [38] . Several investigations have shown the involvement of the COVID-19 infection in the ovarian reserve and can affect the reproductive function of fertile women. Therefore, the latter will be monitored when COVID-19 occurs in women of reproductive age [39] . The consequence of this damage needs to be studied in the post COVID-19 stage. The HPT axis has a clear relation with the immune system, and low levels of T3 and T4 were found in some infections The presence of fever, headache, anosmia, and early ageusia suggests an early interaction between the viral infection and the CNS. Multiple evidences suggest that SARS-CoV-2 is neurotropic, and that it possesses a neuroinvasive mechanism [52] . There is evidence that loss of smell (fifth cranial nerve) may be the gateway for SARS-CoV-2 to enter the CNS. A recent study demonstrated the presence of SARS-CoV-2 RNA and protein in distinct regions of the nasopharynx and brain can alter the HPA axis in two ways, that is, hyperactivated or hypoactivated, mainly due to the dysfunction in negative feedback between the axis and the immune system. The hyperactivation of this axis is mainly attributed to the cytokine-storm mechanism in individuals infected with SARS-CoV-2, related to lung damage and fatality. Similarly, another potential mechanism for SARS-CoV-2 for over activating this axis is the decrease in the angiotensin-converting enzyme 2 levels (ACE2). Contrariwise, the HPA is hypo-activated by TNF-α and Transforming growth factor beta (TGF-β); thus, it is possible that a certain number of cytokines that are elevated in patients with COVID-19 are involved in the hypocortisolism associated with this disease, being the main cause of depression in convalescent patients To date, it is theorized that the interaction between the Spike protein located in the SARS-CoV-2 membrane and the ACE2 receptor improves the host's tropism. Chatterjee and colleagues [70] explain that the essential part for the entry of the virus into the host cell, mainly for human respiratory epithelial cells, is the viralreceptor interaction. In elderly patients, low immunity is inversely proportional to the viral load, as well as to the increased expression of the ACE2 receptor in hematopoietic cells, cardiopulmonary tissues, macrophages, and monocytes. Meftahi et al. [71] propose that several factors may associate "inflame aging" with the cytokine storm in elderly patients with COVID-19; they can uncontrollably turn on the inflammatory machine in the aging, including the alteration of ACE2 receptor expression, excessive reactive oxygen species (ROS) production, senescent adipocyte activity, the alteration of autophagy and mitophagy, and immune-J o u r n a l P r e -p r o o f senescence, as well as vitamin D (VD) deficiency. Hence, older persons with severe COVID-19 infection cannot shut down their proinflammatory immuneneuroendocrine response (Fig. 2) . In a study in which the disease course was followed in 86 patients with immunemediated inflammatory diseases, the authors included 50 cases of inflammatory J o u r n a l P r e -p r o o f arthritis (rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). These were confirmed cases or highly suspected cases of COVID-19. The main comparison was between out-patient and in-patient management, during which 72% of patients were receiving biologic disease-modifying anti-rheumatic drugs (bDMARD) or Janus kinase (JAK) inhibitors. On comparing comorbidities such as hypertension, diabetes, or chronic obstructive pulmonary disease, these were more common in hospitalized patients than in out-patients. Also, oral glucocorticoids (29 vs. 6%), hydroxychloroquine (21 vs. 7%), and methotrexate (43 vs. 15%) were more frequently utilized in hospitalized patients, whereas biologicals (mostly TNFblockers and anti-IL12/23 agents) were more common in out-patients. All of this could suggest a certain possible protective effect of these biologics to prevent the occurrence of a cytokine-release syndrome in patients with rheumatic diseases, with this remaining controversial [80] . On the other hand, SLE possesses similarities with COVID-19, such as the multiorgan complications of interstitial pneumonia, cytopenia, and arthralgia. The evidence of the immune-neuroendocrine axes involved is solid and opens the possibility of future trials with hormonal therapies in order to restore the homeostasis of the immune-neuroendocrine system. 1. The immune-neuroendocrine system is essential to maintain homeostasis during stress situations. Older adults, patients with autoimmune rheumatic diseases, and with other comorbidities have an altered immuneneuroendocrine system response. Director-General's opening remarks at the media briefing on COVID19 WHO Declares COVID-19 a Pandemic World Health Organization. WHO coronavirus disease (COVID-19) dashboard Pathogenesis of COVID-19 from a cell biology perspective C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a metaanalysis Why does COVID-19 disproportionately affect older people? Aging Cytokine storm Molecular links between endocrine, nervous and immune system during chronic stress Network of immune-neuroendocrine interactions Immune-neuro-endocrine interactions: facts and hypotheses COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal SARS-CoV-2 and COVID-19: from the bench to the bedside Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Neuroimmunoendocrine system in health and disease Neuroendocrine-immune interactions during viral infections Prevalence, psychological responses and sssociated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic Immuneneuroendocrine interactions and autoimmune diseases Immune Modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection The impact of infectious diseases upon neuroendocrine circuits Is the immune neuroendocrine system the connection between epipharyngitis and chronic fatigue syndrome induced by HPV vaccine? Editorial Hypothalamic-pituitary-adrenal axis in HIV infection and disease Dysfunction of the hypothalamicpituitary-adrenal axis in HIV infection and disease Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia Upregulated Local Cytokine Production in Recurrent Tonsillitis Compared with Tonsillar Hypertrophy The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis Report: Adrenal pathology findings in severe COVID-19: an autopsy Study The hypothalamicpituitary-gonadal axis: immune function and autoimmunity Sex steroids mediate bidirectional interactions between hosts and microbes The role of androgens in COVID-19 Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation Male fertility and the COVID-19 pandemic: systematic review of the literature Analysis of ovarian injury associated with COVID-19 disease in reproductive Front Med (Lausanne). 2021; 8:635255 Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions HIV and thyroid dysfunction Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management Impact of COVID-19 on the thyroid gland: an update Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: post-vaccination ASIA syndrome 60 Years of Neuroendocrinology: the hypothalamo-prolactin axis Prolactin: structure, function, and regulation of secretion Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common antiemetics the wonder drug to fight coronavirus? Med Hypotheses Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity Pituitary apoplexy associated with acute COVID-19 infection and pregnancy Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Progress in research on SARS-Cov-2 infection causing its infection mechanism COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance. Cells Inflammasomes and pyroptosis as therapeutic targets for COVID-19 COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study The stimulation of thrombosis by hypoxia The neurological manifestations of COVID-19: a review article Fulminant cerebral edema as a lethal manifestation of COVID-19 Case 26-2020: a 60-year-old woman with altered mental status and weakness on the Left Side COVID-19 and neurological impairment: hypothalamic circuits and beyond COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis Mechanisms and implications of Age-Associated impaired innate interferon secretion by dendritic cells: a mini-review COVID-19 and the elderly: insights into pathogenesis and clinical decisionmaking Psycho-neuroendocrine-immune interactions in COVID-19: potential impacts on mental health Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19 The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID 19 infection: the contribution of "inflame aging Rheumatic musculoskeletal diseases and COVID-19 A review of the first 6 months of the pandemic Impacts of fatigue, stress, and perceived health status on women with rheumatic diseases: a comparison study Sex steroids and autoimmune rheumatic diseases: state of the art Impact of infections in autoimmune rheumatic diseases and pregnancy COVID-19 and autoimmune diseases Autoantibodies against type I IFNs in patients with life-threatening COVID-19 The importance of the type I interferon system in autoimmunity Prolactin as an immunomodulatory factor in psoriatic arthritis Covid-19 in immune-mediated inflammatory diseases -case series from COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review Steroids in COVID-19: an overview Testosterone's role in COVID-19 Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism